DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,767 filers reported holding DANAHER CORPORATION in Q4 2020. The put-call ratio across all filers is 0.97 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,534 | -3.0% | 18,275 | -6.1% | 0.17% | -2.9% |
| Q2 2023 | $4,672 | -22.3% | 19,465 | -18.4% | 0.17% | -21.9% |
| Q1 2023 | $6,010 | -39.6% | 23,846 | -36.4% | 0.22% | -40.0% |
| Q4 2022 | $9,944 | -99.9% | 37,465 | -4.1% | 0.36% | -4.5% |
| Q3 2022 | $10,088,000 | +4.1% | 39,056 | +2.2% | 0.38% | +5.8% |
| Q2 2022 | $9,691,000 | -10.3% | 38,224 | +3.8% | 0.36% | -2.7% |
| Q1 2022 | $10,799,000 | -28.6% | 36,814 | -19.9% | 0.37% | -30.4% |
| Q4 2021 | $15,120,000 | +1.6% | 45,955 | -6.0% | 0.53% | -0.9% |
| Q3 2021 | $14,885,000 | +8.8% | 48,893 | -4.1% | 0.54% | +16.5% |
| Q2 2021 | $13,683,000 | +15.7% | 50,986 | -3.0% | 0.46% | +4.1% |
| Q1 2021 | $11,830,000 | +5.0% | 52,559 | +3.6% | 0.44% | -5.3% |
| Q4 2020 | $11,272,000 | +1.1% | 50,741 | -2.0% | 0.47% | -9.1% |
| Q3 2020 | $11,144,000 | +20.8% | 51,755 | -0.8% | 0.52% | +7.9% |
| Q2 2020 | $9,224,000 | +27.5% | 52,163 | -0.2% | 0.48% | +17.2% |
| Q1 2020 | $7,236,000 | -0.5% | 52,282 | +10.3% | 0.41% | +19.3% |
| Q4 2019 | $7,276,000 | – | 47,410 | – | 0.34% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RobecoSam USA, Inc. | 74,961 | $7,572,000 | 9.43% |
| Corvid Peak Capital Management, LLC | 250,000 | $25,250,000 | 8.54% |
| CORTLAND ASSOCIATES INC/MO | 310,508 | $31,361,000 | 6.88% |
| Southpoint Capital Advisors LP | 1,250,000 | $126,250,000 | 6.75% |
| GREEN VALLEY INVESTORS LLC | 2,168,594 | $219,027,000 | 6.70% |
| DAVIS-REA LTD. | 75,080 | $7,595,000 | 5.39% |
| CADINHA & CO LLC | 247,143 | $24,961,000 | 5.35% |
| Espalier Global Management LLC | 47,100 | $4,757,000 | 5.25% |
| Spears Abacus Advisors LLC | 398,334 | $40,232,000 | 5.10% |
| GCA INVESTMENT MANAGEMENT, LLC | 158,064 | $15,964,000 | 5.01% |